Over the last 10 months we’ve been busy working with our partners in the Lieberman Lab at the University of Notre Dame (UND) and their Distributed Pharmaceutical Analytical Laboratory group (DPAL) to develop a platform for conducting verification and reporting of drug APIs (active pharmaceutical ingredients) and safety. Our goal has been to develop a…
It’s been a little while since we’ve given you an update on what’s happening with ARTiFACTS Verify – and that’s because it’s been all hands on deck building on our successful pilot and scaling up our platform. We’ve got a lot to tell you so keep an eye on the blog over the coming weeks. …
Recently, the US Food and Drug Administration (FDA) took the uncommon step of allowing temporary imports of a chemotherapy drug to ease a shortage in the United States of America. The drug – cisplatin – is made by a Chinese lab and will be imported without receiving formal USFDA approval. With more than 90% of…
Today, virtually every country is impacted by substandard or falsified drugs entering their system, from generics to more expensive treatments for cancer and pain management. And the full extent of this problem is not known – but the WHO conservatively estimates that 200 million people are affected. Up to 2 billion people around the world…
The pharmaceutical industry plays a pivotal role in safeguarding public health by ensuring the timely and reliable distribution of life-saving medications worldwide. However, the complexities of the global pharmaceutical supply chain are increasing, and the industry is facing several critical challenges that demand immediate attention. This article delves into the top four critical challenges confronting…